Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups
Guido Bisping(Boehringer Ingelheim (Germany)), Joachim Kienast(Boehringer Ingelheim (Germany))
Cited by 36
Related Papers
Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3–Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma
|Clinical Cancer Research|2009|32